Cardiac cell therapy: pre-conditioning effects in cell-delivery strategies

References

• Wollert KC, Drexler H. Cell therapy for the treatment of coronary heart disease: a critical appraisal. Nat Rev Cardiol. 2010;7:204–15.
   PubMed Web of Science ®Google Scholar
• Akar AR, Durdu S, Arat M, Kilickap M, Kucuk NO, Arslan O, . Five-year follow-up after transepicardial implantation of autologous bone marrow mononuclear cells to ungraftable coronary territories for patients with ischaemic cardiomyopathy. Eur J Cardiothorac Surg. 2009;36:633–43.
   PubMedGoogle Scholar
• Zhang H, Chen H, Wang W, Wei Y, Hu S. Cell survival and redistribution after transplantation into damaged myocardium. J Cell Mol Med. 2010;14:1078–82.
   PubMedGoogle Scholar
• Wu KH, Mo XM, Han ZC, Zhou B. Stem cell engraftment and survival in the ischemic heart. Ann Thorac Surg. 2011;92:1917–25.
   PubMed Web of Science ®Google Scholar
• Traverse JH, McKenna DH, Harvey K, Jorgenso BC, Olson RE, Bostrom N, . Results of a phase 1, randomized, double-blind, placebo-controlled trial of bone marrow mononuclear stem cell administration in patients following ST-elevation myocardial infarction. Am Heart J. 2010;160:428–34.
   PubMed Web of Science ®Google Scholar
• Strauer BE, Yousef M, Schannwell CM. The acute and long-term effects of intracoronary Stem cell Transplantation in 191 patients with chronic heARt failure: the STAR-heart study. Eur J Heart Fail. 2010;12:721–9.
   PubMed Web of Science ®Google Scholar
• Quyyumi AA, Waller EK, Murrow J, Esteves F, Galt J, Oshinski J, . CD34(+) cell infusion after ST elevation myocardial infarction is associated with improved perfusion and is dose dependent. Am Heart J. 2011;161:98–105.
   PubMedGoogle Scholar
• Hu S, Liu S, Zheng Z, Yuan X, Li L, Lu M, . Isolated coronary artery bypass graft combined with bone marrow mononuclear cells delivered through a graft vessel for patients with previous myocardial infarction and chronic heart failure a single-center, randomized, double-blind, placebo-controlled clinical trial. J Am Coll Cardiol. 2011;57:2409–15.
   PubMed Web of Science ®Google Scholar
• Wu KH, Zhou B, Yu CT, Cui B, Lu SH, Han ZC, . Therapeutic potential of human umbilical cord derived stem cells in a rat myocardial infarction model. Ann Thorac Surg. 2007;83:1491–8.
   PubMed Web of Science ®Google Scholar
• Chen K, Bai H, Arzigian M, Gao YX, Bao J, Wu WS, . Endothelial cells regulate cardiomyocyte development from embryonic stem cells. J Cell Biochem. 2010;111:29–39.
   PubMedGoogle Scholar
• Li Z, Wilson KD, Smith B, Kraft DL, Jia F, Huang M, . Functional and transcriptional characterization of human embryonic stem cell-derived endothelial cells for treatment of myocardial infarction. PLoS One. 2009;4:e8443.
   Google Scholar
• Theus MH, Wei L, Cui L, Francis K, Hu X, Keogh C, . In vitro hypoxic preconditioning of embryonic stem cells as a strategy of promoting cell survival and functional benefits after transplantation into the ischemic rat brain. Exp Neurol. 2008;210:656–70.
   PubMedGoogle Scholar
• Kofidis T, de Bruin JL, Yamane T, Balsam LB, Lebl DR, Swijnenburg RJ, . Insulin-like growth factor promotes engraftment, differentiation, and functional improvement after transfer of embryonic stem cells for myocardial restoration. Stem Cells. 2004;22:1239–45.
   PubMed Web of Science ®Google Scholar
• Hug K, Hermeren G. Do we still need human embryonic stem cells for stem cell-based therapies? Epistemic and ethical aspects. Stem Cell Rev. 2011;7:761–74.
   Google Scholar
• Pasha Z, Wang Y, Sheikh R, Zhang D, Zhao T, Ashraf M. Preconditioning enhances cell survival and differentiation of stem cells during transplantation in infarcted myocardium. Cardiovasc Res. 2008;77:134–42.
   PubMed Web of Science ®Google Scholar
• Hu X, Yu SP, Fraser JL, Lu Z, Ogle ME, Wang JA, . Transplantation of hypoxia-preconditioned mesenchymal stem cells improves infarcted heart function via enhanced survival of implanted cells and angiogenesis. J Thorac Cardiovasc Surg. 2008;135:799–808.
   PubMed Web of Science ®Google Scholar
• Tang YL, Zhu W, Cheng M, Chen L, Zhang J, Sun T, . Hypoxic preconditioning enhances the benefit of cardiac progenitor cell therapy for treatment of myocardial infarction by inducing CXCR4 expression. Circ Res. 2009;104:1209–16.
   PubMed Web of Science ®Google Scholar
• Chang JC, Hsu SH, Chen DC. The promotion of chondrogenesis in adipose-derived adult stem cells by an RGD-chimeric protein in 3D alginate culture. Biomaterials. 2009;30: 6265–75.
   PubMed Web of Science ®Google Scholar
• Suzuki K, Smolenski RT, Jayakumar J, Murtuza B, Brand NJ, Yacoub MH. Heat shock treatment enhances graft cell survival in skeletal myoblast transplantation to the heart. Circulation. 2000;102:III216–21.
   PubMed Web of Science ®Google Scholar
• Niagara MI, Haider H, Jiang S, Ashraf M. Pharmacologically preconditioned skeletal myoblasts are resistant to oxidative stress and promote angiomyogenesis via release of paracrine factors in the infarcted heart. Circ Res. 2007;100:545–55.
   PubMed Web of Science ®Google Scholar
• Wu KH, Mo XM, Zhou B, Lu SH, Yang SG, Liu YL, . Cardiac potential of stem cells from whole human umbilical cord tissue. J Cell Biochem. 2009;107:926–32.
   PubMed Web of Science ®Google Scholar
• Park IH, Zhao R, West JA, Yabuuchi A, Huo H, Ince TA, . Reprogramming of human somatic cells to pluripotency with defined factors. Nature. 2008;451:141–6.
   PubMed Web of Science ®Google Scholar
• Okita K, Ichisaka T, Yamanaka S. Generation of germline-competent induced pluripotent stem cells. Nature. 2007; 448:313–7.
   PubMed Web of Science ®Google Scholar
• Carvajal-Vergara X, Sevilla A, D'Souza SL, Ang YS, Schaniel C, Lee DF, . Patient-specific induced pluripotent stem-cell-derived models of LEOPARD syndrome. Nature. 2010; 465:808–12.
   PubMed Web of Science ®Google Scholar
• Nelson TJ, Martinez-Fernandez A, Yamada S, Perez-Terzic C, Ikeda Y, Terzic A. Repair of acute myocardial infarction by human stemness factors induced pluripotent stem cells. Circulation. 2009;120:408–16.
   PubMed Web of Science ®Google Scholar
• Tokunaga M, Liu ML, Nagai T, Iwanaga K, Matsuura K, Takahashi T, . Implantation of cardiac progenitor cells using self-assembling peptide improves cardiac function after myocardial infarction. J Mol Cell Cardiol. 2010;49:972–83.
   PubMed Web of Science ®Google Scholar
• Zhang J, Wilson GF, Soerens AG, Koonce CH, Yu J, Palecek SP, . Functional cardiomyocytes derived from human induced pluripotent stem cells. Circ Res. 2009;104:e30–41.
   PubMed Web of Science ®Google Scholar
• Hare JM, Traverse JH, Henry TD, Dib N, Strumpf RK, Schulman SP, . A randomized, double-blind, placebo-controlled, dose-escalation study of intravenous adult human mesenchymal stem cells (prochymal) after acute myocardial infarction. J Am Coll Cardiol. 2009;54:2277–86.
   PubMed Web of Science ®Google Scholar
• Barbash IM, Chouraqui P, Baron J, Feinberg MS, Etzion S, Tessone A, . Systemic delivery of bone marrow-derived mesenchymal stem cells to the infarcted myocardium: feasibility, cell migration, and body distribution. Circulation. 2003;108:863–8.
   PubMed Web of Science ®Google Scholar
• Menasche P, Hagege AA, Scorsin M, Pouzet B, Desnos M, Duboc D, . Myoblast transplantation for heart failure. Lancet. 2001;357:279–80.
   PubMed Web of Science ®Google Scholar
• Viswanathan C, Davidson Y, Cooper K, Tipnis S, Pujari G, Kurian VM. Transplantation of autologous bone marrow derived mesenchymal stem cells trans-epicardially in patients undergoing coronary bypass surgery. Indian Heart J. 2010;62:43–8.
   PubMedGoogle Scholar
• Strauer BE, Brehm M, Zeus T, Kostering M, Hernandez A, Sorg RV, . Repair of infarcted myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans. Circulation. 2002;106:1913–8.
   PubMed Web of Science ®Google Scholar
• Yousef M, Schannwell CM, Kostering M, Zeus T, Brehm M, Strauer BE. The BALANCE study: clinical benefit and long-term outcome after intracoronary autologous bone marrow cell transplantation in patients with acute myocardial infarction. J Am Coll Cardiol. 2009;53:2262–9.
   PubMed Web of Science ®Google Scholar
• Grajek S, Popiel M, Gil L, Breborowicz P, Lesiak M, Czepczynski R, . Influence of bone marrow stem cells on left ventricle perfusion and ejection fraction in patients with acute myocardial infarction of anterior wall: randomized clinical trial: impact of bone marrow stem cell intracoronary infusion on improvement of microcirculation. Eur Heart J. 2010;31:691–702.
   PubMed Web of Science ®Google Scholar
• Thompson CA, Nasseri BA, Makower J, Houser S, McGarry M, Lamson T, . Percutaneous transvenous cellular cardiomyoplasty. A novel nonsurgical approach for myocardial cell transplantation. J Am Coll Cardiol. 2003;41:1964–71.
   PubMed Web of Science ®Google Scholar
• Fuchs S, Kornowski R, Weisz G, Satler LF, Smits PC, Okubagzi P, . Safety and feasibility of transendocardial autologous bone marrow cell transplantation in patients with advanced heart disease. Am J Cardiol. 2006;97:823–9.
   PubMed Web of Science ®Google Scholar
• Perin EC, Dohmann HF, Borojevic R, Silva SA, Sousa AL, Mesquita CT, . Transendocardial, autologous bone marrow cell transplantation for severe, chronic ischemic heart failure. Circulation. 2003;107:2294–302.
   PubMed Web of Science ®Google Scholar
• Tse HF, Thambar S, Kwong YL, Rowlings P, Bellamy G, McCrohon J, . Prospective randomized trial of direct endomyocardial implantation of bone marrow cells for treatment of severe coronary artery diseases (PROTECT-CAD trial). Eur Heart J. 2007;28:2998–3005.
   PubMed Web of Science ®Google Scholar
• van Ramshorst J, Bax JJ, Beeres SL, Dibbets-Schneider P, Roes SD, Stokkel MP, . Intramyocardial bone marrow cell injection for chronic myocardial ischemia: a randomized controlled trial. JAMA. 2009;301:1997–2004.
   PubMed Web of Science ®Google Scholar
• Krause K, Jaquet K, Schneider C, Haupt S, Lioznov MV, Otte KM, . Percutaneous intramyocardial stem cell injection in patients with acute myocardial infarction: first-in-man study. Heart. 2009;95:1145–52.
   PubMedGoogle Scholar
• Suzuki K, Murtuza B, Fukushima S, Smolenski RT, Varela-Carver A, Coppen SR, . Targeted cell delivery into infarcted rat hearts by retrograde intracoronary infusion: distribution, dynamics, and influence on cardiac function. Circulation. 2004;110:II225–30.
   PubMedGoogle Scholar
• Vicario J, Piva J, Pierini A, Ortega HH, Canal A, Gerardo L, . Transcoronary sinus delivery of autologous bone marrow and angiogenesis in pig models with myocardial injury. Cardiovasc Radiat Med. 2002;3:91–4.
   PubMedGoogle Scholar
• Fukushima S, Coppen SR, Lee J, Yamahara K, Felkin LE, Terracciano CM, . Choice of cell-delivery route for skeletal myoblast transplantation for treating post-infarction chronic heart failure in rat. PLoS One. 2008;3:e3071.
   Google Scholar
• Vicario J, Campo C, Piva J, Faccio F, Gerardo L, Becker C, . One-year follow-up of transcoronary sinus administration of autologous bone marrow in patients with chronic refractory angina. Cardiovasc Revasc Med. 2005;6:99–107.
   PubMedGoogle Scholar
• Hofmann M, Wollert KC, Meyer GP, Menke A, Arseniev L, Hertenstein B, . Monitoring of bone marrow cell homing into the infarcted human myocardium. Circulation. 2005;111: 2198–202.
   PubMed Web of Science ®Google Scholar
• Blocklet D, Toungouz M, Berkenboom G, Lambermont M, Unger P, Preumont N, . Myocardial homing of nonmobilized peripheral-blood CD34 + cells after intracoronary injection. Stem Cells. 2006;24:333–6.
   PubMed Web of Science ®Google Scholar
• Suzuki K, Murtuza B, Beauchamp JR, Brand NJ, Barton PJ, Varela-Carver A, . Role of interleukin-1beta in acute inflammation and graft death after cell transplantation to the heart. Circulation. 2004;110:II219–24.
   PubMedGoogle Scholar
• Li SH, Lai TY, Sun Z, Han M, Moriyama E, Wilson B, . Tracking cardiac engraftment and distribution of implanted bone marrow cells: comparing intra-aortic, intravenous, and intramyocardial delivery. J Thorac Cardiovasc Surg. 2009;137:1225–33.
   PubMed Web of Science ®Google Scholar
• Teng CJ, Luo J, Chiu RC, Shum-Tim D. Massive mechanical loss of microspheres with direct intramyocardial injection in the beating heart: implications for cellular cardiomyoplasty. J Thorac Cardiovasc Surg. 2006;132:628–32.
   PubMed Web of Science ®Google Scholar
• Ingber DE. Mechanical signaling and the cellular response to extracellular matrix in angiogenesis and cardiovascular physiology. Circ Res. 2002;91:877–87.
   PubMed Web of Science ®Google Scholar
• Ciulla MM, Montelatici E, Ferrero S, Braidotti P, Paliotti R, Annoni G, . Potential advantages of cell administration on the inflammatory response compared to standard ACE inhibitor treatment in experimental myocardial infarction. J Transl Med. 2008;6:30.
   PubMedGoogle Scholar
• Zhang M, Methot D, Poppa V, Fujio Y, Walsh K, Murry CE. Cardiomyocyte grafting for cardiac repair: graft cell death and anti-death strategies. J Mol Cell Cardiol. 2001;33:907–21.
   PubMed Web of Science ®Google Scholar
• Gyongyosi M, Posa A, Pavo N, Hemetsberger R, Kvakan H, Steiner-Boker S, . Differential effect of ischaemic preconditioning on mobilisation and recruitment of haematopoietic and mesenchymal stem cells in porcine myocardial ischaemia-reperfusion. Thromb Haemost. 2010;104:376–84.
   PubMedGoogle Scholar
• Laflamme MA, Chen KY, Naumova AV, Muskheli V, Fugate JA, Dupras SK, . Cardiomyocytes derived from human embryonic stem cells in pro-survival factors enhance function of infarcted rat hearts. Nat Biotechnol. 2007;25:1015–24.
   PubMed Web of Science ®Google Scholar
• Herrmann JL, Wang Y, Abarbanell AM, Weil BR, Tan J, Meldrum DR. Preconditioning mesenchymal stem cells with transforming growth factor-alpha improves mesenchymal stem cell-mediated cardioprotection. Shock. 2010;33:24–30.
   PubMed Web of Science ®Google Scholar
• Ren H, Cao Y, Zhao Q, Li J, Zhou C, Liao L, . Proliferation and differentiation of bone marrow stromal cells under hypoxic conditions. Biochem Biophys Res Commun. 2006; 347:12–21.
   PubMed Web of Science ®Google Scholar
• Lu G, Haider HK, Jiang S, Ashraf M. Sca-1+ stem cell survival and engraftment in the infarcted heart: dual role for preconditioning-induced connexin-43. Circulation. 2009;119:2587–96.
   PubMed Web of Science ®Google Scholar
• Kim HW, Haider HK, Jiang S, Ashraf M. Ischemic preconditioning augments survival of stem cells via miR-210 expression by targeting caspase-8-associated protein 2. J Biol Chem. 2009;284:33161–8.
   PubMed Web of Science ®Google Scholar
• Ye L, Haider H, Jiang S, Tan RS, Ge R, Law PK, . Improved angiogenic response in pig heart following ischaemic injury using human skeletal myoblast simultaneously expressing VEGF165 and angiopoietin-1. Eur J Heart Fail. 2007;9:15–22.
   PubMedGoogle Scholar
• Huang J, Zhang Z, Guo J, Ni A, Deb A, Zhang L, . Genetic modification of mesenchymal stem cells overexpressing CCR1 increases cell viability, migration, engraftment, and capillary density in the injured myocardium. Circ Res. 2010;106:1753–62.
   PubMed Web of Science ®Google Scholar
• Retuerto MA, Schalch P, Patejunas G, Carbray J, Liu N, Esser K, . Angiogenic pretreatment improves the efficacy of cellular cardiomyoplasty performed with fetal cardiomyocyte implantation. J Thorac Cardiovasc Surg. 2004;127: 1041–51.
   PubMed Web of Science ®Google Scholar
• Retuerto MA, Beckmann JT, Carbray J, Patejunas G, Sarateanu S, Kane BJ, . Angiogenic pretreatment to enhance myocardial function after cellular cardiomyoplasty with skeletal myoblasts. J Thorac Cardiovasc Surg. 2007; 133:478–84.
   PubMedGoogle Scholar
• Zhu Q, Yu W, Yang X, Hicks GL, Lanzafame RJ, Wang T. Photo-irradiation improved functional preservation of the isolated rat heart. Lasers Surg Med. 1997;20:332–9.
   PubMedGoogle Scholar
• Zhang H, Hou JF, Shen Y, Wang W, Wei YJ, Hu S. Low level laser irradiation precondition to create friendly milieu of infarcted myocardium and enhance early survival of transplanted bone marrow cells. J Cell Mol Med. 2010;14:1975–87.
   PubMedGoogle Scholar